Agent-in-Place - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe
Agent-in-Place
12345678910
Next »

Mice on a Mission

December 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

To ensure the accuracy of scientific testing, protect the subjects to avoid data contamination.

Frozen Assets

November 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

Even when all is well at the facility, one must expect the worst while braving the elements.

Case Closed

October 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

Only the strong survive when it comes to pharmaceutical packaging and shipping.

Compliant or Contraband?

September 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

International trade can be great for business, but breaking border laws can put one in hot water.

Technology Fights Back

August 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

Meticulous system configuration can prevent machines from taking over.

A Lukewarm Reception

July 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

Careful attention to detail will help to prevent valuable assets from "melting" away.

A "Big E" on the Scoreboard

June 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

Even the slightest of errors in exponential calculations can cause the biggest of headaches.

All Eyes Alert

May 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

It's better to catch costly mistakes in the laboratory before they reach the accounting department.

Loose Lips Sink Ships

April 2, 2012
By: Control, a senior compliance officer
Pharmaceutical Technology

Failure to disclose info may work sometimes, but eventually every question will be answered.

12345678910
Next »

ADVERTISEMENT
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
19%
To all process for new products only
14%
To select process for new products only
24%
To select processes for both new and legacy products
19%
Do not use QbD
24%
View Results
Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
FindPharma Custom Search
Featured Jobs

More Jobs
Click here